PharmFIT trial tests pharmacy-based colorectal cancer screening

▪ SCREENING

A two-arm, pragmatic, hybrid type 1 effectiveness-implementation trial is underway in Washington and North Carolina to evaluate whether community pharmacies can expand access to FIT screening for underserved patients due for colorectal cancer screening. (Contemporary Clinical Trials)